Purpose Transoral robotic surgery (TORS) of the tongue base with or without epiglottoplasty represents a novel treatment for obstructive sleep apnea (OSA). The objective was to evaluate the clinical efficacy of TORS of the tongue base with or without epiglottoplasty in patients who had not tolerated or complied with conventional treatment (continuous positive airway pressure or oral appliance). Methods Four-year prospective case series. The primary outcome measure was the apnea-hypopnea index (AHI) in combination with the Epworth Sleepiness Score (ESS). Mean oxygen saturation levels (SaO 2 ) before and after TORS on respective sleep studies were also recorded. Secondary outcome measures included operative time and complications. Patient reported outcome measures (PROMs) assessed included voice, swallow and quality of life. Results Fourteen patients underwent TORS for tongue base reduction with ten having additional wedge epiglottoplasty. A 64 % success rate was achieved with a normal post-operative sleep study in 36 % of cases at 6 months. There was a 51 % reduction in the mean AHI (36.3±21.4 to 21.2±24.6, p=0.02) and a sustained reduction in the mean Epworth Sleepiness Score (p=0.002). Mean SaO 2 significantly increased after surgery compared to pre-operative values (92.9±1.8 to 94.3±2.5, p=0.005). Quality of life showed a sustained improvement 3 months following surgery (p=0.01). No major complications occurred. Conclusions TORS of the tongue base with or without epiglottoplasty represents a promising treatment option with minimal morbidity for selected patients with OSA. Long-term prospective comparative evaluation is necessary to validate the findings of this study.
Introduction
Obstructive sleep apnea (OSA) is a serious health problem affecting at least 2-4 % of the adult population [1] . There is a correlation between the severity of OSA and subsequent cardiovascular and neurocognitive events. Untreated OSA represents a significant mortality risk [2] . Continuous positive airway pressure (CPAP) is the primary treatment modality, especially for more severe cases, although compliance is often suboptimal [3] . Patients unable to tolerate CPAP or those with limited compliance to it therefore require an alternative treatment option.
A variety of surgical interventions have been described. Drug-induced sleep endoscopy (DISE) is a valuable diagnostic tool to assess the upper airway and identify the level(s) of obstruction. The base of the tongue (BOT) is recognized as a significant site of obstruction in many patients with OSA [4] . The traditional external tongue base approach provides excellent exposure although the potential for morbidity is significant [5] . Minimally invasive transoral techniques include radiofrequency ablation, laser-assisted oropharyngeal surgery, submucosal minimally invasive lingual excision (SMILE) and coblation endoscopic lingual lightening (CELL) [6] [7] [8] [9] . However, there is limited evidence of their long-term efficacy, and suboptimal transoral access remains an issue [7, 10, 11] . BOT collapse is therefore challenging to address, and the existing techniques are associated with variable success rates depending on how success is defined [11] [12] [13] [14] . Numerous techniques to address the obstruction at the BOT level have been described including pharyngeal suspension suture with repose bone screws, mortised genioplasty, tongue radiofrequency treatment, surgical reduction of the tongue base via midline glossectomy and hyoepiglottoplasty [7, [15] [16] [17] [18] .
Transoral robotic surgery (TORS) was first reported in 2010 as a modification of open tongue base reduction and hyoid epiglottopexy to treat OSA [19] . The approach permits multi-planar tissue transaction of tissues at any angle. Several studies suggest improved surgical access to the BOT with this technique [20] [21] [22] [23] [24] . The average volume of tissue removed from the BOT during TORS is reportedly 10 ml although this figure ranges from 1.5 to 40 ml [20, 22, 24, 25] . The majority of these studies are retrospective, have short follow-up times and incorporate TORS as part of a primary multimodality treatment strategy that includes the soft palate and nasal cavity.
There remains a critical need to improve the surgical treatment of patients with OSA. Careful patient selection is crucial to maximize the effectiveness and reduce complications of the procedure. The objective was to conduct a prospective evaluation of the efficacy of TORS of the tongue base with or without epiglottoplasty used as a "salvage" procedure in patients with OSA who had not tolerated or failed to comply with other available treatment options.
Materials and methods

Ethical approval
The study received approval from the NHS Health Research Authority (National Ethics Service Committee London, Protocol Reference Number: 08/H0721/97).
Study design
Prospective case series conducted between July 2010 and August 2014.
Selection criteria
Criteria for recruitment included patients with (1) moderateto-severe OSA confirmed by sleep study (defined as an apneahypopnea index (AHI)≥15episodes/h), (2) failure to tolerate or comply with other OSA treatment modalities including CPAP and mandibular advancement device (MAD), (3) BMI<35kgm −2 and (4) predominant BOT collapse with or without epiglottic collapse evaluated by drug-induced sedation endoscopy (DISE). Exclusion criteria were contraindications to elective surgery due to severe comorbidities (e.g. uncontrolled coagulopathy, morbid obesity, immunocompromize), limited mouth opening and a failure to attend post-operative follow-up for a minimum period of 12 months.
All patients underwent transoral robotic tongue base reduction (TBR). Ten patients, who had concurrent epiglottic prolapse identified by DISE, also underwent wedge epiglottoplasty. Informed consent was obtained from all patients prior to surgery, and the possibility of the need for overnight endotracheal intubation and intensive care unit (ICU) admission, nasogastric tube insertion and tracheostomy were routinely included as part of the standard consent process.
TORS set-up and operative procedure
Nasotracheal intubation was performed to facilitate access to the tongue base and epiglottis. A Boyle-Davis gag is used to keep the mouth open. The operating room (OR) configuration described by O'Malley et al. was used [25] . The patient is positioned supine with a shoulder roll. The da Vinci robot® (Intuitive Surgical, Sunnyvale, CA) is docked at an angle of 45°relative to the base of the operating table. The TORS setup is shown in Fig. 1 .
Tongue base reduction
TBR is performed by thulium laser ablation (2013 nm, 15 W), commencing in the midline from the foramen cecum and circumvallate papillae to the vallecula. A 1-cm mucosal bridge between the base of the epiglottis and the tongue represents the posterior limit and is employed to minimize edema at the epiglottic base (Fig. 2) . The lateral limits are 1 cm to either side of the midline to a depth of 2 cm. Any excess lingual tonsillar tissue is additionally ablated down to muscle.
Epiglottoplasty
A wedge-shaped laser excision of the upper one half of the epiglottis is performed (Fig. 2) . The plane of resection is above the pharyngoepiglottic folds to minimize the chance of aspiration and also avoid bleeding from branches of the superior laryngeal artery.
All patients received perioperative and post-operative steroids (dexamethasone 2 mg three times daily for 5 days) to minimize edema, nausea and pain. In addition, antibiotics (coamoxiclav 625 mg three times daily for 5 days), analgesia (paracetamol 1 g four times daily, ibuprofen 400 mg three times daily and codeine 30 mg as required) and benzydamine hydrochloride gargles (4-6 times daily for 2 weeks) were given post-operatively.
Outcome measures and follow-up
Patients underwent pre-and post-operative (6 months after surgery) sleep study and AHI, and mean oxygen saturation levels (SaO 2 ) and Epworth Sleepiness Scores (ESS) were measured. Primary outcome was a surgical response with "success" defined as an AHI<20 and an ESS<10 as well as a greater than 50 % reduction in the baseline AHI.
Secondary outcome measures included operative time, blood loss and complications. Patient reported outcome measures (PROMs) assessing voice, swallowing and quality of life were measured using validated assessment tools. Voice satisfaction was rated by the Voice Handicap Index 2 (VHI-2) questionnaire. Swallowing was assessed using the MD Anderson Dysphagia Inventory (MDADI) questionnaire. Global quality of life (QoL) was assessed using the EQ-5D assessment tool that comprises a descriptive system and EQ-VAS. The former comprises an assessment of mobility, self-care, usual activities, pain or discomfort and anxiety or depression. Each self-rated as 1= no problems, 2 =some problems and 3=severe problems. The EQ-VAS is a 0 to 100 visual analogue scale where 0 signifies "worst" imaginable health state and 100 "best" imaginable health state. Patients were followed-up at 2 weeks, 3, 6, 12, 18 and 24 months.
Statistical analysis
Continuous data are displayed as mean±standard deviation (SD). Statistical evaluation was performed using chisquare test for categorical variables and Mann-Whitney and Wilcoxon test for continuous variables. The comparisons were performed using SPSS software version 21.0 (SPSS Inc., Chicago, IL). Statistical significance was accepted when p<0.05.
Results
Fourteen patients were assessed. Patients' demographics and characteristics are summarized in Table 1 . Median follow-up was 24 months (mean=18.9±6.2, range 12-24). There was no difference between the pre-and post-operative mean BMI (28.7±2.8 vs. 27.8±2.7, respectively, p=0.10). 
Outcome measures
Primary outcomes
There was a significant reduction in the mean post-op AHI compared to pre-op AHI (21.2±24.6 vs. 36.3±21.4, respectively, p = 0.026, n = 11). This represents a mean AHI percentage reduction of 50.7±38.9 %. Mean SaO 2 significantly increased after surgery compared to preoperative values (92.9±1.8 to 94.3±2.5, p=0.005, n=11) (Fig. 3) . Patient demographics and pre-operative and postoperative data are presented in Table 2 . Three patients refused a post-operative sleep study because they reported feeling significantly better. These patients all had a normal post-operative ESS but were not included to calculate success rate. Of the remaining 11 patients, the success rate was 64 % (7/11 patients). Thirty-six percent (4/11) had a normal post-operative sleep study (AHI<5) and 91 % of the patients (10/11) demonstrated an improvement in sleep study parameters, although not necessarily consistent with successful outcome. Of the successful group, approximately 18 % required CPAP based on their AHI following surgery. Post-operative results have been stratified into clinically relevant levels (Table 3 ). In one patient, the AHI became worse although there was an improvement in the oxygen desaturation index compared to the pre-operative level (88 vs. 96.2).
There was a significant sustained reduction in the mean ESS 2 weeks after surgery (p=0.002). All patients had a normal ESS at 6 months onwards (Fig. 4) .
Secondary outcomes
The mean robotic set-up and console time was 21±9 and 45± 21 min, respectively. The mean duration of TBR and epiglottoplasty was 31±14 and 20±10 min, respectively. The mean intra-operative blood loss was 8±4 ml.
The first two patients were prophylactically kept intubated in ICU overnight and also kept as inpatients for 48 h prior to discharge as a matter of precaution. The remaining cohort (12/ 14 patients) were discharged within 24 h having been commenced on a soft diet. No major complications occurred. Nasogastric tube insertion and tracheostomy were not required in any of the patients. One patient had a minor secondary bleed that occurred 21 days following surgery and was successfully managed conservatively. Another patient developed dysgeusia, and two further patients reported persistent odynophagia to solids. These symptoms were temporary and all resolved within 6 weeks. The mean VHI-2 score was significantly higher representing a worsening of voice function at the first postoperative day and 2 weeks following surgery (p<0.05). The mean score subsequently normalized to baseline levels by 3 months.
The mean MDADI score was significantly lower representing a worsening of swallow at the first postoperative day and 2 weeks following surgery. The mean score returned to baseline 3 months following surgery. The mean EQ-5D quality of life score significantly improved following surgery in all patients from 3 months onwards (Fig. 5) .
Discussion
This is the first prospective study with a minimum follow-up of 12 months to assess outcomes following TORS of the tongue base with or without epiglottoplasty for OSA without other concomitant procedures. The results demonstrate that TORS represents a promising treatment option for selected patients with moderate-severe OSA who have not tolerated or complied with other treatment modalities. Through improved visualization and ergonomics over "conventional" (non-robotic) approaches, TORS overcomes the difficulty associated with accessing the BOT and offers comparable efficacy to open procedures with less morbidity. All participants had previously tried other treatment modalities including CPAP and MAD, and approximately two thirds of the cohort had undergone previous surgery for OSA. TORS was reserved as an alternative option when other existing treatment options failed. Patients with obstruction at the BOT and/or epiglottis are ideal candidates. In this study, patients with a BMI> 35kgm −2 were excluded which is in keeping with our clinical practice for OSA surgery. As with conventional (non-robotic) transoral approaches, appropriate exposure of the target region is crucial. This is where the improved access and ergonomics provided by the robotic system make TORS of the tongue base with or without AHI apnea-hypopnea index, ESS Epworth Sleeping Score, OSAHS obstructive sleep apnea-hypopnea syndrome, CPAP continuous positive airway pressure epiglottoplasty, potentially advantageous over non-robotic approaches for the surgical treatment of OSA as the latter are confined to straight line visualization making it difficult to operate around corners [25] . Suboptimal access has major implications for poor outcome, such as inadequate tissue resection or abandoning the procedure. Biometric measures of the extent of mouth opening (Mallampatti grade), neck circumference, hyoid-mental length and mandibular body height are important when assessing patient suitability for TORS [26] . Pre-operative cephalometric measurements obtained from imaging are also useful [27, 28] . Several techniques have been described to perform BOT reduction using the da Vinci robot®. These include an inverted pyramid or triangular resection [19, 20] . Laser ablation was used in this study. The mean set-up and operative times in this study are comparable [22] [23] [24] . Regardless of the technique used, neurovascular structures are at risk during surgery, and a sound appreciation of the relevant transoral anatomy is required. The average distance from the foramen cecum to the hypoglossal/lingual artery neurovascular bundle is 15-20 mm [29, 30] . In order to minimize the risk of injury, a midline to lateral approach was adopted with the lateral extent no more than 1 cm from the midline.
The amount of tissue ablation varied between patients and was determined by the individual's transoral anatomy and the degree of prolapse during DISE. The ablative technique precluded estimation of volumetric tissue reduction in vivo. The extent of tongue base reduction necessary to achieve a good functional result during TORS is not known and must be balanced against the potential morbidity. Regarding the epiglottoplasty, preservation of the vallecula mucosa and sufficient epiglottic remnant is important to minimize the risk of aspiration.
With the exception of the first two patients, who remained in hospital for 2 days as a matter of precaution, all patients were discharged within 24 h after surgery. This is in contrast with other studies that report routine endotracheal intubation, tracheostomy and an average hospital stay of 3.5 days (range 1-14 days) [20, [22] [23] [24] . The difference may reflect the selection criteria and treatment rationale. In this study, TORS was not part of extensive multilevel surgery as reported in the literature. Furthermore, laser ablation may represent a less aggressive technique compared with resection.
In accordance with others, this study demonstrates that TORS for BOT reduction can be safely performed without the need for tracheostomy or conversion to open surgery [20, 22] . A success rate of 64 % was achieved at 6 months. Looking at the success rates of non-robotic techniques in the literature, these are variables depending on the technique used and the definition of "success". For radiofrequency ablation, a 31 % reduction in short-term ESS (odds ratios (OR) 0.69, 95 % confidence interval (CI) 0.63-0.75), which was maintained beyond 12 months (OR 0.68, 95 % CI 0.43-0.73), has been reported on a meta-analysis of 16 studies [7] . For laser-assisted oropharyngeal surgery, post-operative polysomnography at 4 months or longer following surgery showed a 73 % reduction in AHI to a mean of 12.9 per hour in a prospective case controlled study of 20 patients [6] . For SMILE, in a retrospective study (n=48), success rates were reported at 64.6 % (p=0.024) [8] and for CELL, also in a retrospective study (n=25), the AHI was shown to decrease from 45.7±21.7 to 12.8±8.2 events/h (p<0.001) 6 months after surgery [9] . The differences in success rates are in all cases minimal, and as the data are from either retrospective analyses or case series, no reliable comparison can be made. Though the numbers in this study are low, the results for Fig. 4 Impact on excessive daytime sleepiness following TORS using Epworth Sleepiness Score (single asterisk indicates p<0.05 and double asterisk indicates p<0.01). Bars represent standard error for mean score TORS as a novel surgical modality in the treatment OSA seem promising. It remains to be seen whether subsequent larger studies will support this preliminary data.
Although a patient can be considered "cured" according to the criteria described for definition of success, moderate OSA requiring further treatment may persist. CPAP was introduced in 18 % (2/11) of the patient cohort following TORS. Both patients, previously intolerant of oral CPAP, were able to tolerate nasal CPAP because of reduced pressures.
There was a significant mean AHI reduction of 51 %. However, three patients did not respond as planned or expected with one experiencing a worsening of the AHI post-operatively. The cause for this remains unclear.
In terms of ESS, all patients normalized 6 months after surgery (ESS<10). This is a subjective measurement and does not reduce the risk of OSA complications, although it does reflect the patients' quality of life. There was a significant improvement in quality of life 3 months following surgery.
There were no complications relating to hypoglossal nerve injury, lingual artery injury, speech problems or aspiration. Transient voice disturbance was resolved within a few weeks of surgery. Odynophagia was present for 2 weeks but no further intervention was necessary apart from analgesia and a short course of oral dexamethasone. The majority of patients started a soft diet immediately after surgery, and swallow function returned to normal after 4 weeks. One patient complained of transient dysgeusia (1/14, 7.1 %), which was resolved within 6 weeks. Taste disturbance is a recognized complication following transoral surgery either due to direct injury to the taste buds or lingual nerve neurapraxia from the prolonged pressure of the tongue blade of the Boyle-Davis gag on the lingual nerve. One patient (1/14, 7.1 %) had a minor secondary haemorrhage 21 days following surgery that was managed conservatively.
Certain limitations in the methodology must be acknowledged. The sample size is small and there was no control Fig. 5 Impact on swallow function following TORS using the MDADI questionnaire and on quality of life (QoL) following TORS using the EQ-5D questionnaire (single asterisk indicates p<0.05 and double asterisk indicates p<0.01). Bars represent standard error for mean score group. Selection bias must also be acknowledged as a potential confounding factor. There is also a potential "performance" bias console since expertise increased as the study progressed, and greater clinical experience was attained.
Truly, valid comparisons with other studies are difficult because several differences exist. Firstly, the definition of success varies between studies. Secondly, existing studies utilize TORS as part of multilevel surgery strategy and thirdly, most studies are retrospective with a follow-up time that ranges between 3 and 6 months [20, 23, 24] . In comparison, this study is prospective with a much longer follow-up period and uses validated outcome measures.
Conclusion
The clinical efficacy and cost effectiveness of TORS of the tongue base with or without epiglottoplasty compared to CPAP and the existing transoral non-robotic surgical techniques warrant further evaluation. TORS represents a promising treatment option for selected patients with moderatesevere OSA who have not tolerated or complied with other treatment modalities. Long-term comparative evaluation in a larger patient cohort is necessary to validate the findings of this study.
